Stage 1 treatment of pediatric overweight and obesity: a pilot and feasibility randomized controlled trial

Steven D Stovitz1, Jerica M Berge, Rachel J Wetzsteon

  • 11 Department of Family Medicine and Community Health, University of Minnesota , Minneapolis, MN.

Childhood Obesity (Print)
|January 14, 2014
PubMed

Insights

This study tested the first stage of pediatric obesity treatment in children aged 4-9. The intervention showed feasibility and potential benefits for BMI and behavior, supporting further research into multi-stage obesity management.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Behavioral Science

Background:

  • Staged clinical treatment protocols for pediatric obesity are recommended but lack empirical testing.
  • Understanding the effectiveness of the initial, least intensive treatment stage is crucial for developing comprehensive management strategies.

Purpose of the Study:

  • To evaluate the feasibility and preliminary effectiveness of the lowest intensity stage of a recommended pediatric obesity treatment program.
  • To compare changes in BMI z-score and behavioral issues in children receiving the intervention versus a control group.

Main Methods:

  • A randomized controlled trial involving children aged 4 to <9 years with a BMI at or above the 85th percentile.
  • Intervention based on the "Prevention plus, Stage 1" model.
  • Intent-to-treat (ITT) analysis compared changes in BMI z-score and parental-reported behavioral issues over 3 months.

Main Results:

  • Enrollment included 72 children, with 64 completing the 3-month follow-up.
  • Both groups showed improvement in mean BMI z-score, with the intervention group demonstrating a slightly greater adjusted change (-0.04 vs. -0.07).
  • Over half of children in both groups improved their BMI z-score; the intervention group had a higher proportion of improvement (72% vs. 55%).
  • The intervention group showed comparative improvements in several behavioral indicators.

Conclusions:

  • The initial stage of current pediatric obesity treatment recommendations is feasible to implement in primary care.
  • This lowest intensity intervention may offer benefits for lifestyle changes and behavioral outcomes in children.
  • Findings provide a basis for future research protocols testing comprehensive, multi-staged approaches for pediatric overweight and obesity.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410